Government gives green light to CNB: Genetically modified virus to fight against COVID-19
Royal Decree 8/2020 has approved various and extraordinary measures, including authorization to the National Biotechnology Centre (CNB) to use any genetically modified organism (GMO) they believe appropriately to combat the SARS-CoV-2 (COVID-19) pandemic.
The EMA & The FDA co-presede the first regulatory workshop on Covid-19 for vaccine development
Yesterday 18th of March, 2020, the first global regulatory workshop on COVID-19, was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).
AEMPS publishes recommendations during the crisis period by COVID-19 in Spain
Exceptional measures applicable to clinical trials to manage problems arising from the COVID-19 emergency
Sermes CRO awarded at the II Comunity of Madrid Awards of LA RAZÓN
The Counselor of Economy, Employment and Competitiveness of the Community of Madrid, Manuel Giménez, yesterday presided at the headquarters of the newspaper the delivery of the II Community of Madrid Awards of LA RAZÓN.
Next 10-11 FEB 2020 will be the 5th @EUCROF Conference on Clinical Research in Amsterdam
Next 10-11 FEB 2020 will be the 5th @EUCROF Conference on Clinical Research in Amsterdam
Sermes CRO obtains the certificate of excellence in Business Management
On November 19, Sermes CRO obtained the certificate of excellence in Business Management from elEconomista.es and einforma.es.
ISPOR 2019
Sermes CRO, and as a member of PSN Research, is attending the ISPOR 2019 Copenhagen Congress (The worldwide leading professional society in Heath Economics and Outcomes Research). Society’s goal is to promote HEOR excellence in order to improve global healthcare decision-making.
Sermes CRO continues their international expansion process with their first Headquarters in Latin America (LATAM)
SERMES CRO continues their internationalization process with the opening of an office in Santiago de Chile consolidating their service´s coverage in LATAM.
Sermes CRO at the Colloquium-discussion “Sport YES, Injuries NO”, organized by the OAFI Foundation
Sermes CRO as a collaborator of the OAFI Foundation, has been invited on May 29, 2019, to the Colloquium-discussion “Sport YES, Injuries NO”, organized by the OAFI Foundation together with the medical services of Atlético de Madrid.
Sermes CRO awarded as the most Innovative company global supplier 2019 by MSD company (Merck Sharp and Dhome)
Sermes CRO Team, led by their CEO and founder Antonio Berlanga, accompanied by the responsible for clinical research and resposible of business development, has been awarded as the most company as the most Innovative company global supplier 2019 by MSD company (Merck Sharp and Dhome).